文献速递类风湿关节炎

新型人源化TCR转基因小鼠模型研究类风湿关节炎瓜氨酸化腱生蛋白C反应性T细胞

A new humanised TCR transgenic mouse model to study T cells reactive to citrullinated tenascin C, a relevant autoantigen in rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2026-09-10

研究构建了表达源于类风湿关节炎(RA)患者的T细胞受体(TCR)的人源化转基因小鼠,该TCR识别HLA-DRB1*04:01限制的瓜氨酸化腱生蛋白C22(citTNC22)。该模型可支持抗原特异性CD4+ T细胞的功能研究与操作,为抗原特异性治疗开发提供工具。

要点

  • hTCR-tg小鼠仅在HLA-DR4限制下显示正常CD4+ T细胞发育。
  • 嵌合hTCR保持对citTNC22的特异性,不与天然TNC22或其他瓜氨酸化自身抗原交叉反应。
  • 蛋白免疫后hTCR-tg小鼠经关节周围citTNC攻击可发生关节炎。

核心结论

  • 表达RA患者来源自身反应性TCR的hTCR-tg小鼠可产生功能性抗原特异性且HLA限制的CD4+ T细胞。

研究设计与样本

  • 通过基因工程构建表达鼠恒定域和人V(D)J序列的嵌合TCR的hTCR-tg小鼠,识别HLA-DRB1*04:01限制的citTNC22。
  • 在鼠H-2b和人源化HLA-DR4背景下,用全光谱流式细胞术、细胞因子ELISA和Fluorospot assay进行免疫表型分析。
  • 研究citTNC蛋白免疫后抗citTNC抗体和关节炎的发生。

主要发现

  • hTCR T细胞的胸腺选择在两种MHC II类等位基因间不同,仅在HLA-DR4限制下观察到正常CD4+ T细胞发育。
  • 嵌合hTCR在体外和离体保持citTNC22特异性,不与天然TNC22或其他瓜氨酸化自身抗原交叉反应。
  • hTCR-tg CD4+ T细胞在体内对抗原攻击有反应,并支持IgG类别转换和抗原特异性抗体产生。
  • 蛋白免疫的hTCR-tg小鼠在关节周围citTNC攻击后发生关节炎。

临床怎么用

  • 该模型可用于研究RA中citTNC反应性T细胞的功能及抗原特异性治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Autoreactive T cells recognising citrullinated antigens, although rare and difficult to study, are implicated in rheumatoid arthritis (RA). To allow functional studies and manipulation of such T cells, we have generated and characterised transgenic mice expressing a T-cell receptor (TCR) cloned from a patient with RA and reactive with a prominent target, citrullinated tenascin C (citTNC). METHODS: A humanised TCR transgenic (hTCR-tg) mouse recognising the citrullinated tenascin C22 (citTNC22) antigen in an HLA-DRB1*04:01 (HLA-DR4) restricted manner was developed by genetically engineering a chimeric TCR expressing murine constant domains and human V(D)J sequences. hTCR-tg mice were immune phenotyped in murine H-2b and humanised HLA-DR4 backgrounds using full-spectrum flow cytometry, cytokine enzyme-linked immunosorbent assays, and Fluorospot assays at steady state and after antigen challenge. Additionally, we investigated the presence of antibodies to citTNC and arthritis after citTNC protein immunisation. RESULTS: Thymic selection of hTCR T cells differed between the 2 major histocompatibility complex class II alleles, with normal CD4+ T-cell development observed solely under HLA-DR4 restriction. The chimeric hTCR maintained its citTNC22 specificity in vitro and ex vivo, without cross-reactivity to native TNC22 or other citrullinated autoantigens. hTCR-tg CD4+ T cells responded to antigen challenge in vivo and provided support to IgG class-switch and antigen-specific antibody production. Moreover, protein-immunised hTCR-tg mice developed arthritis after periarticular challenge with citTNC. CONCLUSIONS: hTCR-tg mice expressing an RA patient-derived autoreactive TCR develop functional antigen-specific and HLA-restricted CD4+ T cells. The combination of humanised HLA-DR4 and TNC22 mice will be a valuable tool in the development of antigen-specific therapies translatable to human disease.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Schülein M, Afonso M, Sijbranda M, et al. A new humanised TCR transgenic mouse model to study T cells reactive to citrullinated tenascin C, a relevant autoantigen in rheumatoid arthritis. Ann Rheum Dis. 2026. PMID: 42722588. doi:10.1016/j.ard.2026.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。